HCW Biologics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| HRT FINANCIAL LP | 05/14/2026 | 266.39 K | $95.00 K | 100.00% | 12.70% |
| VIRTU FINANCIAL LLC | 05/14/2026 | 47.81 K | $17.00 K | 100.00% | 2.28% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 35.89 K | $12.92 K | 155.65% | 1.71% |
| CITADEL ADVISORS LLC | 05/15/2026 | 26.08 K | $9.39 K | 17.71% | 1.24% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2026 | 14.84 K | $5.34 K | 229.46% | 0.71% |
| JANE STREET GROUP, LLC | 05/12/2026 | 14.13 K | $5.09 K | 100.00% | 0.67% |
| 05/15/2026 | 12.02 K | $4.33 K | 100.00% | 0.57% | |
| CITIGROUP INC | 05/11/2026 | 10.53 K | $3.79 K | 1,052,700.00% | 0.50% |
| GOLDEN STATE WEALTH MANAGEMENT, LLC | 04/28/2026 | 10.00 K | $3.60 K | 0.00% | 0.48% |
| UBS GROUP AG | 05/05/2026 | 9.22 K | $3.32 K | 430.25% | 0.44% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 1.90 K | $685 | 100.00% | 0.09% |
| WELLS FARGO & COMPANY/MN | 05/11/2026 | 1.00 K | $360 | 0.00% | 0.05% |
| ADVISOR GROUP HOLDINGS, INC. | 05/15/2026 | 26 | $9 | 0.00% | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 05/07/2026 | 2 | $1 | 100.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 0 | $0 | -100.00% | 0.00% |
| J.W. COLE ADVISORS, INC. | 04/23/2026 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| DRW SECURITIES, LLC | 05/13/2026 | 0 | $0 | -100.00% | 0.00% |
| ARMISTICE CAPITAL, LLC | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
HCW Biologics Inc institutional Ownership - FAQ's
During the previous two years, 20 institutional investors and hedge funds held shares of HCW Biologics Inc. The most heavily invested institutionals were:
HRT FINANCIAL LP: 266,393
Virtu Financial LLC: 47,809
GEODE CAPITAL MANAGEMENT, LLC: 35,886
CITADEL ADVISORS LLC: 26,083
Tower Research Capital LLC (TRC): 14,839
JANE STREET GROUP, LLC: 14,134
21.44% of HCW Biologics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 495.91 K shares in the last 24 months. This purchase volume represents approximately $292.59 K in transactions.